“I cannot check you in, but that is not BA’s problem.” This was the infuriating answer I got from a flight attendant with the captivating charm of the Wandsworth prison ...
I apologize for my strong and passionate reaction to the new Medseek facebook page. In case you missed Phil Baumann’s or Eileen O’Brien’s excellent posts on this matter: Sara Baker ...
This is Part II of the analysis on pharma’s twitter presence. If you remember, we saw in part I that some pharma companies seem to be more engaged than others on twitter. ...
Upon popular demand, I decided to kick off this year with an update of my Pharma twittersphere analysis. In this analysis I will compare how many people follow the pharmacos’ ...
It is time. Time to prove that quality health information in the hands of empowered patients leads to improved health, also in Europe. Time to demonstrate that social media provides ...
The FDA hearing on social media took place almost a month ago already and a lof of ink (or pixel for that matter) has flown since on what was presented. ...
Researching the latest EU commission view point on social media, I came across this very upsetting conclusion from a review on the state of patient information in Europe: Today huge ...
Exactly 20 years ago today, one of the most horrific monuments of the cold war came down: the Berlin wall. I remember strolling through East and West Berlin some days ...
The first 10 weeks of Health Care Social Media Europe’s (#hcsmeu) existence has been characterised not only by our listening, learning, linking and frenetic debate, but also by our constant ...
Last week, I had the chance to assist an amazing event: The annual meeting of the European chapter of Healthcare Businesswomen Association (HBA). The HBA is the most powerful association ...